Real-world data on the use of CD4/6 inhibitors

Dr Monica Cejuela, a medical oncologist from the Virgen del Rocio Hospital at Sevilla, presented in this poster real-world data on the use of the three different CDK4/6 inhibitors in combination with endocrine therapy. This study aims to establish a risk prediction model for disease progression and assess whether there are differences in efficacy between them.